In 2023, Sichuan Kelun-Biotech Biopharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Sichuan Kelun-Biotech Biopharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 |
|---|---|
Total Scope 1 | 6,335.07a |
Total Scope 2 | |
Unspecified Calculation Method | 13,568.27a |
Total Scope 3 | N/A |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 29.2266a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of Sichuan Kelun-Biotech Biopharmaceutical amounted to 19,903.34 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
In 2023, the total Scope 1 emissions of Sichuan Kelun-Biotech Biopharmaceutical were 6,335.07 metric tons of CO₂ equivalent (tCO₂e).a
In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 13,568.27 tCO₂e without specifying the calculation method.a
In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported its Scope 2 emissions using an unspecified methodology.a
In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 6,335.07 tCO₂e and total revenues of USD 217 millions. This translates into an emissions intensity of 29.23 tCO₂e per millions USD.a
In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported a Scope 1 emissions intensity of 29.23 tCO₂e per millions USD. Compared to the peer group median of 10.66, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2023, Sichuan Kelun-Biotech Biopharmaceutical ranked 19 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Sichuan Kelun-Biotech Biopharmaceutical among the least efficient performers, with one of the highest emissions intensities in its sector.a